news.cision.com

Shelton, CT—August 16, 2023—International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide Sectra One Cloud, its enterprise imaging cloud subscription service for diagnostic imaging, to a US based health system serving a multi-million strong patient community.Sectra will, as the sole imaging IT provider, oversee and deliver the end-to-end infrastructure through a turnkey, fully managed SaaS agreement. Expanding on Sectra’s previously implemented solution for Ophthalmology this enterprise imaging solution will initially be leveraged by the

Carbonhand available in the US through Veterans Healthcare Supply Solutions

Bioservo signs a wholesale distributor agreement with Veterans Healthcare Supply Solutions for sales of Carbonhand in the US. The initial intent of the agreement is to make Carbonhand available for Veterans Administration Facilities (VA) and Department of Defense Healthcare Facilities (DoD). The agreement can also be expanded to include other customer segments. Veterans Healthcare Supply Solutions (VHSS) has over 30 years of healthcare distribution management experience and represents leading manufacturers to federal government agencies. Established in 2010, VHSS has been a

Genova Property Group Interim Report January–June 2023

January-June 2023 period · Rental income amounted to SEK 254.5m (185.7), an increase of 37%. · Net operating income amounted to SEK 186.4m (132.3), an increase of 41%. · Income from property management decreased 57% to SEK 24.1m (56.3), of which income from property management attributable to shareholders was SEK 15.2m (31.1), corresponding to SEK -0.33 (0.74) per share. The decline was mainly due to negative changes in the values of properties in joint ventures of appropriately SEK -29m and higher interest expense. · Net income after tax amounted to SEK -148.3m (342.5),

Major Milestone Achieved: SiPore® Data Strengthens Path to World's First Oral Medical Device for Blood Sugar Control in Prediabetics

Wed, Aug 16, 2023 08:25 CET

· Sigrid Therapeutics announces publication of key scientific study showing activity and stability of amylase remain unaffected when confined in SiPore® mesoporous silica pores · Results provide further support for medical device claim that MSPs act exclusively as “molecular sieves” · Sigrid’s patented MSPs technology SiPore® to physically prevent digestive enzymes from interacting with food already being used in prediabetes, diabetes, weight control and oral health applications Stockholm, August 16[th], 2023: Sigrid Therapeutics today announced the publication of a scientific study

Biosergen Receives Full Subscription Guarantees for Warrant Exercise from Largest Shareholders and Executive Management

Stockholm, Sweden – August 16 – Biosergen AB ("Biosergen" or the “Company"), a clinical stage biotech company specializing in the development of innovative anti-fungal therapies, is pleased to announce significant guarantees from its largest shareholders and executive management to fully exercise their warrants during the ongoing warrant exercise period.Östersjöstiftelsen and Rosetta Capital, the Company’s largest shareholders, will exercise all their warrants. In addition CEO Peder M. Andersen and CFO Niels Laursen will subscribe to all of their warrants. Moreover, COO Tine Olesen, who

2020 Bulkers Ltd. (2020) - Results for the second quarter of 2023

Oslo, Norway, August 16, 2023 2020 Bulkers Ltd. (“2020 Bulkers” or the “Company”), today announced its unaudited financial and operating results for the three and six months ended June 30, 2023. Key events during the second quarter of 2023 · The Company reported net profit of US$4.8 million and EBITDA of US$11.1 million for the second quarter of 2023. · Achieved average time charter equivalent earnings of approximately US$23,800 per day, gross. · The Company declared total cash distributions of US$0.19 per share for the months of April, May and June 2023. Subsequent

Gaming Innovation Group reports Q2 2023

Gaming Innovation Group Inc. (GiG) reports Q2 2023 revenues* of €31.1 million and an adjusted EBITDA of €14.0 million. “The second quarter of 2023 has proven another step forward for GiG with the business reaching another all-time high in revenues. We now look into the second half of the year with total focus on ensuring strong growth mechanics, continued operational improvement and long-term scalability for GiG”, says Richard Brown, CEO of GiG. Financial Highlights · Gaming Innovation Group achieved all-time high revenues* in Q2 2023 amounting to €31.1m (22.1), an increase of

Fortum Loviisa power plant’s annual outage 2023 to begin

The annual outage of Fortum’s Loviisa nuclear power plant will begin with Unit 2 on Sunday, August 20th, followed by the servicing of Unit 1. This year, both units will undergo the short so-called refuelling outage. The annual outages are estimated to last a total of about 37 days. During the annual outage, one quarter of the fuel will be replaced. In addition to the fuel replacement, both units will undergo various preliminary maintenance work, inspections, repairs and tests. Additionally, the automation modernisation of Loviisa Unit 1’s emergency generators, which was started in the

Volvo Trucks starts selling electric trucks in Malaysia

Volvo Trucks has now started sales of heavy battery electric trucks in Malaysia. Volvo is the first manufacturer to offer zero exhaust emission trucks in this market. Volvo has started sales of heavy battery electric trucks in Malaysia.Volvo Trucks is continuing its entry into new markets with its battery electric truck offering. Malaysia is the latest example, where the logistics company Swift Haulage Berhad has purchased two Volvo FM Electric trucks. Malaysia has a national plan to reach net zero greenhouse gas emissions by 2050, and electrifying road transports is one important

Polymer Factory Sweden AB (publ) Interim Report Q2 2023

The period in summarySecond quarter, April-June 2023 · Net sales increased with over 70% compared to the same period 2022 · The Company exhibited and presented at the ASMS conference in Houston in June · The Company continued development of its calibration technology SpheriCal® to expand into new modalities Year to date, January-June 2023 · Net sales increased with close to 50% compared to the same period 2022 · The Board of Directors resolved on a share issue, with subsequent approval by the EGM · The Company raised approx. SEK 6,1 million* through a rights issue

Kesko’s financial reporting and Annual General Meeting in 2024

The 2024 calendar for Kesko Group's financial reporting concerning the years 2023 and 2024 is as follows: Year 2023 financial statements release 30 January 2024 Year 2023 Annual Report Week 9 at the latest (incl. the financial statements andthe Report by the Board of Directors) Year 2024 3-month interim report 25 April 2024 Year 2024 6-month half-year financial report 23 July 2024 Year 2024 9-month interim report

Bioretec unveils its revitalized Scientific Advisory Board (SAB), focusing on driving innovations in orthopedic implants

Wed, Aug 16, 2023 07:30 CET

Bioretec Ltd Press release 16 August 2023 at 9:00 a.m. EESTBioretec Ltd, a pioneering company dedicated to advancing orthopedic biodegradable implants, has refined and expanded its esteemed Scientific Advisory Board (SAB). To further strengthen its strategic focus areas, Bioretec has assembled a distinguished group of key opinion leaders to represent expertise from the refocused RemeOs™ portfolio. These top-tier experts and surgeons, renowned for their significant contributions to orthopedics and medical research, will form Bioretec's Scientific Advisory Board. These eminent

Archer Limited: Record EBITDA in Q2 and additional backlog secured

Hamilton, Bermuda (August 16, 2023) Second Quarter 2023 Highlights · Revenue of $295 million; up 20% YOY · Adjusted EBITDA of $31.9 million; up 52% YOY · EBITDA of $30.0 million; up 54% YOY · EBIT-margin of 6.3%, totaling $18.7 million · On track to meet upper range of our financial guidance for 2023 · Secured a five-year ~$50 million coiled tubing and pumping contract in the UK Subsequent events · Awarded a $165 million contract for permanent plug and abandonment (P&A) of 32 wells in UK · Awarded a 5-year contract for P&A, Fishing, Cleaning and Rental

Sitowise’s Half-year Report January – June 2023: Solid growth in spite of mixed market environment

Wed, Aug 16, 2023 07:30 CET

Sitowise Group Plc, Half-year Report, 1 January - 30 June 2023, 16 August 2023 at 8:30 am EEST This release is a summary of Sitowise Group Plc’s Half-Year Report January-June 2023. The complete report is attached to this release as a PDF file, and also available on the company’s website at www.sitowise.com/investors/reports-and-presentations April – June in brief · Net sales increased by 9% to EUR 56.5 (51.7) million. In constant currency net sales growth was 11%. · Organic net sales grew by 5% (4%). · Adjusted EBITA was EUR 4.5 (4.9) million, or 8.0% (9.5%) of net sales.

New member of Wihlborgs Nomination Committee

Wed, Aug 16, 2023 07:30 CET

Länsförsäkringar Fondförvaltning appoints Johannes Wingborg as a member of the Nomination Committee for the Wihlborg's 2024 AGM.Johannes Wingborg, who is owner manager at Länsförsäkringar Fondförvaltning, replaces Åsa Wallenberg. The Nomination Committee for Wihlborg's AGM in 2024 thus consists of Göran Hellström (Backahill AB), Elisabet Jamal Bergström (SEB Investment Management AB), Johannes Wingborg (Länsförsäkringar Fondförvaltning) and Caroline Sjösten (Swedbank Robur fonder). Wihlborgs Fastigheter AB (publ)

Lundbeck’s revenue increased by 13% (+10% CER) to DKK 10 billion in the first six months of 2023

Wed, Aug 16, 2023 07:28 CET

Key highlights Lundbeck’s revenue increased by 13% (+10% CER[1]) to DKK 9,982 million in the first six months of 2023, representing growth in all regions with the U.S. and Europe contributing strongly · United States: DKK 4,787 million (+16%; +14% CER) · Europe: DKK 2,333 million (+13%; +13% CER) · International Markets: DKK 2,736 million (+2%; +5% CER) The revenue of Lundbeck’s strategic brands increased by 18% (+18% CER), reaching DKK 6,632 million, representing 66% of total revenue · Brintellix[®]/Trintellix[®]: DKK 2,156 million (+5%; +6% CER) · Rexulti[®]/

INTERIM REPORT FOR THE SECOND QUARTER 2023 NEW WAVE GROUP AB

PERIOD 1 APRIL – 30 JUNE 2023 · Net sales amounted to SEK 2,304.5 million, which was 14% higher than last year (SEK 2,019.2 million). Currency changes affected net sales positively by 5% and acquired business by 9%. · Operating result amounted to SEK 363.9 (351.0) million. · Result for the period amounted to SEK 259.6 (265.0) million. · Earnings per share amounted to SEK 1.96 (2.00).* · Cash flow from operating activities amounted to SEK 230.1 (68.1) million. PERIOD 1 JANUARY – 30 JUNE 2023 · Net sales amounted to SEK 4,440.0 million, which was 17% higher than

BerGenBio ASA: Invitation to second quarter and half year 2023 results webcast

Bergen, Norway, 16 August 2023 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL inhibitors for severe unmet medical needs, will be announcing its results for the second quarter and half year 2023 on Wednesday 23 August 2023. The briefing will take place at the Conference “Vestland på Børs” at 10:45 am CEST where BerGenBio's senior management team will provide a business update. The presentation will webcast live, a link will be available at www.bergenbio.com in the Investors/Financial Reports section

Nurses’ intentions to quit increased during the pandemic despite their high resilience

Nurses’ intentions to leave nursing increased during the COVID-19 pandemic, a recent study from the University of Eastern Finland shows. Yet, nurses estimated their resilience to be high.The COVID-19 pandemic caused stress everywhere in the world, and especially for healthcare professionals. Coping with a pandemic calls for an ability to respond to challenging and difficult situations. It also requires crisis management, good leadership and faith in the future, all of which are linked to experienced resilience. “Resilience refers to a person recognising and being able to utilise their

Interim report Q2 2023

“We had a solid second quarter with sales of SEK 9.5 billion (9.1) and an adjusted EBITA margin of 9.7 percent (9.7). Market conditions remain challenging but efforts across our business units are yielding results, with strong cash flow from operating activities and a sustained trend towards our 10 percent adjusted EBITA margin target. In addition, we further strengthened our balance sheet as we completed strategic divestments and extended the maturity profile of our debt portfolio”, says Daniel Kaplan, CEO of Storskogen.Second quarter (1 April-30 June 2023) · Net sales increased by 4

Flex LNG – Second Quarter 2023 Earnings Release